29-Dec-09 2:00 PM CST
Tylenol Arthritis Recall
McNeil Consumer Healthcare announced that it has expanded its voluntary recall of Tylenol Arthritis Pain Caplet 100-count bottles, with the distinctive red EZ-OPEN CAP, to all available lots. The move is an expansion of the original recall of five lots back in November. The recall was issued amid consumer complaints of a moldy odor coming from the bottle that induced nausea, stomach pain, vomiting, and diarrhea. As of last week, the company has extended the recall to all available lots of Tylenol Arthritis as a precaution.
The source of the smell comes from a chemical known as 2,4,6-tribromoanisole, a chemical used to treat wooden pallets to transport and store packaging materials. As of now, officials are still unsure how the chemical came into contact specifically with the Tylenol Arthritis 100-count bottles. As a precaution, they have halted the release of the 100-count Tylenol Arthritis bottles until January 2010 as they work to move production to a new facility. In a release issued by the FDA, health officials say that the adverse effects of the chemical are temporary and non-serious.
Consumers who have purchased the product should contact McNeil immediately at 1-888-222-6036 for instructions on a refund or replacement. Officials are advising consumers who feel they may have been affected by the recalled lot to consult their primary care physician. Consumers may also report their concerns to the FDA MedWatch website. A full list of the recalled lots is available on the Tylenol web site.
McNeil Consumer Healthcare is a division of McNeil-PPC, Inc., a subsidiary of Johnson & Johnson. The company markets over-the-counter and prescription pharmaceuticals including the complete lines of Tylenol and Motrin IB (ibuprofen) products for adults and children.
Copyright © 2009 NPTA. All rights reserved.
Rating: 4.50 / 5.00
-
2 ratings
Comments:
•
del.icio.us
digg
facebook
E-mail this article to a friend (requires login).
For additional information on this Article article, please contact:
Kristina Michel
(888) 247-8700
Related Documents:
Content Tags: article •
Tags: CPhT Johnson Johnson McNeil NPTA pharmacy pharmacy technician recall Tylenol Tylenol Arthritis
Other Recent Articles:
- Intensive Corticosteroid Treatment May be Best in Treating Severe Lupus 28-Jul-10
- FDA Suspends Enrollment in Avandia Clinical Trial 27-Jul-10
- New Painless Flu Patch Could Change How People Receive Vaccines 21-Jul-10
- FDA Warns of Stolen Advair 20-Jul-10
- FDA Advisory Panel Reviews Avandia 15-Jul-10
- Scientists Discover Potent HIV Antibodies That Could Boost Vaccine Research 14-Jul-10
- Study Ties Gene in Fat Cells to Type 2 Diabetes 9-Jul-10
- International Study to Examine Benefits of Aspirin in the Elderly 8-Jul-10
- First Ever Generic Version of Effexor XR FDA-Approved 30-Jun-10
- P&G Recalls Nasal Spray 30-Jun-10
Return to Pharmacy Technician Articles Search
